FGL1调节巨细胞功能,并通过LAG3-TNFR1轴增强肝脏修复
Yuzhe Wu1, Qinghua Fang2, Yanyun Chen1
1Guangdong Provincial Key Laboratory of New Drug Screening & NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, China.
纤维素样蛋白1 (FGL1) 通过调节巨细胞功能来减少肝炎. 它通过LAG3抑制促炎信号,在受伤模型中促进肝脏修复.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
背景情况:
- 纤维素样蛋白1 (FGL1) 是一种与淋巴细胞激活基因3 (LAG3) 相互作用的肝脏因子.
- FGL1在肝脏修复中的免疫调节作用尚未完全理解.
研究的目的:
- 研究FGL1在肝损伤期间调节巨细胞功能的机制.
- 为了确定FGL1对肝脏修复过程的影响.
主要方法:
- 使用了急性肝损伤 (ALI) 的小鼠模型.
- 骨髓衍生巨细胞 (BMDMs) 用于研究FGL1的影响.
- 分析细胞因子的产生,巨细胞的两极分化和信号通路 (NF-κB,TNFR1).
主要成果:
- 在肝损伤模型中,FGL1显著降低了促炎性细胞因子的产生.
- 与LAG3结合的FGL1降低了瘤亡因子受体1 (TNFR1) 的调节,并抑制了NF-κB信号传递.
- FGL1促进了M2巨细胞的两极分化,并抑制了M1的激活,增强了肝脏的再生.
结论:
- 通过调节巨细胞极化,FGL1在解决肝炎和促进修复方面发挥着至关重要的作用.
- FGL1代表了炎症性肝病的潜在治疗标.
相关概念视频
09:29Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
08:10A Simple and Efficient Method to Isolate Macrophages from Mixed Primary Cultures of Adult Liver Cells
08:54Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion
Hypothalamic-Pituitary Axis
10:32Using Q Suture to Enhance Resistance to Gap Formation and Tensile Strength of Repaired Flexor Tendons
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity


